loading
前日終値:
$17.48
開ける:
$17.53
24時間の取引高:
505.27K
Relative Volume:
0.95
時価総額:
$502.63M
収益:
$157.75M
当期純損益:
$-29.73M
株価収益率:
-15.96
EPS:
-1.16
ネットキャッシュフロー:
$-21.00M
1週間 パフォーマンス:
-4.98%
1か月 パフォーマンス:
+27.39%
6か月 パフォーマンス:
+4.16%
1年 パフォーマンス:
-13.79%
1日の値動き範囲:
Value
$17.39
$19.00
1週間の範囲:
Value
$16.71
$19.69
52週間の値動き範囲:
Value
$8.04
$25.88

Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile

Name
名前
Arcturus Therapeutics Holdings Inc
Name
セクター
Healthcare (1157)
Name
電話
(858) 900-2660
Name
住所
10628 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Name
職員
176
Name
Twitter
@ArcturusRx
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
ARCT's Discussions on Twitter

ARCT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ARCT
Arcturus Therapeutics Holdings Inc
18.51 486.34M 157.75M -29.73M -21.00M -1.16
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-28 開始されました Scotiabank Sector Outperform
2025-01-28 開始されました BTIG Research Buy
2024-08-12 開始されました Leerink Partners Outperform
2023-12-13 開始されました Canaccord Genuity Buy
2023-07-24 開始されました William Blair Outperform
2023-05-11 アップグレード H.C. Wainwright Neutral → Buy
2022-11-14 再開されました Wells Fargo Overweight
2022-11-10 ダウングレード Robert W. Baird Neutral → Underperform
2022-11-03 アップグレード Citigroup Neutral → Buy
2022-11-02 アップグレード Barclays Underweight → Equal Weight
2022-08-10 ダウングレード Raymond James Mkt Perform → Underperform
2022-07-19 再開されました Cantor Fitzgerald Overweight
2022-05-11 アップグレード Robert W. Baird Underperform → Neutral
2022-04-21 ダウングレード Citigroup Buy → Neutral
2022-01-31 アップグレード Raymond James Underperform → Mkt Perform
2021-08-12 ダウングレード Raymond James Mkt Perform → Underperform
2021-08-11 ダウングレード Goldman Neutral → Sell
2021-08-10 ダウングレード Robert W. Baird Neutral → Underperform
2021-07-02 開始されました Cantor Fitzgerald Overweight
2021-06-25 再開されました Goldman Neutral
2021-06-21 ダウングレード Barclays Equal Weight → Underweight
2021-06-04 再開されました Robert W. Baird Neutral
2021-02-17 ダウングレード B. Riley Securities Neutral → Sell
2021-01-19 ダウングレード B. Riley Securities Buy → Neutral
2021-01-15 ダウングレード B. Riley Securities Buy → Neutral
2021-01-07 開始されました Wells Fargo Overweight
2020-12-29 ダウングレード Barclays Overweight → Equal Weight
2020-12-29 ダウングレード H.C. Wainwright Buy → Neutral
2020-12-29 ダウングレード Raymond James Outperform → Mkt Perform
2020-12-29 ダウングレード Robert W. Baird Outperform → Neutral
2020-12-23 ダウングレード ROTH Capital Buy → Sell
2020-12-08 繰り返されました B. Riley Securities Buy
2020-12-07 繰り返されました B. Riley Securities Buy
2020-10-26 開始されました Barclays Overweight
2020-10-06 開始されました Citigroup Buy
2020-08-26 開始されました Piper Sandler Overweight
2020-07-30 再開されました ROTH Capital Buy
2020-07-16 開始されました Raymond James Outperform
2020-07-13 開始されました B. Riley FBR Buy
2020-06-09 ダウングレード WBB Securities Buy → Hold
2020-02-11 開始されました Robert W. Baird Outperform
2020-02-07 開始されました Guggenheim Buy
2020-02-06 開始されました Guggenheim Buy
2019-04-05 開始されました H.C. Wainwright Buy
2018-09-20 アップグレード WBB Securities Buy → Strong Buy
2018-01-22 開始されました Chardan Capital Markets Buy
すべてを表示

Arcturus Therapeutics Holdings Inc (ARCT) 最新ニュース

pulisher
Aug 18, 2025

Is Arcturus Therapeutics Holdings Inc. the Top Chart Pick This Week2025 Key Lessons & AI Driven Price Forecasts - kangso.co.kr

Aug 18, 2025
pulisher
Aug 17, 2025

Arcturus Therapeutics Holdings Inc. Added to High Probability Setup ListWeekly Stock Summary & Accurate Technical Buy Alerts - beatles.ru

Aug 17, 2025
pulisher
Aug 16, 2025

Arcturus Therapeutics Stock Rises After Promising Mid-Stage Data for OTC Deficiency Treatment - MSN

Aug 16, 2025
pulisher
Aug 14, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q2 2025 Earnings Call Transcript - MSN

Aug 14, 2025
pulisher
Aug 14, 2025

Is Now a Good Time to Reenter Arcturus Therapeutics Holdings Inc.July 2025 Breakouts & Safe Capital Allocation Plans - beatles.ru

Aug 14, 2025
pulisher
Aug 13, 2025

Arcturus Therapeutics (ARCT) Surges 29% on Intraday Frenzy: What’s Fueling the Biotech Breakout? - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

Intapp Posts Better-Than-Expected Earnings, Joins… - inkl

Aug 13, 2025
pulisher
Aug 12, 2025

Arcturus Therapeutics (NASDAQ:ARCT) Upgraded at Wall Street Zen - MarketBeat

Aug 12, 2025
pulisher
Aug 12, 2025

Arcturus Therapeutics Receives Bullish Rating Amid Promising Cystic Fibrosis and COVID-19 Vaccine Progress - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Citi Raises Arcturus Therapeutics Price Target to $49, Keeps Buy Rating - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

William Blair Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating - 富途牛牛

Aug 12, 2025
pulisher
Aug 12, 2025

Mercury Systems Surges 24.6% After Reporting Better-Than-Expected Q4 Earnings, Green Dot, Arcturus Therapeutics, and Other Stocks Rise Amid US Market Gains - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Mercury Systems Posts Better-Than-Expected Earnings,… - inkl

Aug 12, 2025
pulisher
Aug 12, 2025

Arcturus Therapeutics shares rise 29.68% intraday after positive interim Phase 2 data for ARCT-810. - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Real Messenger Corporation shares rise 28.05% intraday after Arcturus Therapeutics announced positive Phase 2 data for ARCT-810. - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Arcturus Therapeutics: Wells Fargo Maintains Overweight, PT Down to $42 from $45 - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Wells Fargo lowers Arcturus Therapeutics stock price target to $42 on model updates - Investing.com Canada

Aug 12, 2025
pulisher
Aug 12, 2025

Arcturus Therapeutics shares rise 6.23% premarket after positive interim Phase 2 data for ARCT-810. - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress - BioSpace

Aug 12, 2025
pulisher
Aug 12, 2025

Arcturus Therapeutics Reports Q2 2025 Earnings and Pipeline Progress - TipRanks

Aug 12, 2025
pulisher
Aug 11, 2025

Arcturus Therapeutics Q2 2025 Earnings Call Transcript - MarketBeat

Aug 11, 2025
pulisher
Aug 11, 2025

Arcturus Therapeutics Holdings Inc earnings missed by $3.55, revenue fell short of estimates - Investing.com Nigeria

Aug 11, 2025
pulisher
Aug 11, 2025

Arcturus Therapeutics Advances CF and OTC Programs, Plans Regulatory Meetings in 2026 - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Transcript : Arcturus Therapeutics Holdings Inc., Q2 2025 Earnings Call, Aug 11, 2025 - MarketScreener

Aug 11, 2025
pulisher
Aug 11, 2025

Arcturus Tightens Its Belt As Analysts Stay Bullish - Finimize

Aug 11, 2025
pulisher
Aug 11, 2025

Arcturus Therapeutics (ARCT) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Aug 11, 2025
pulisher
Aug 11, 2025

Arcturus Therapeutics: Q2 Earnings Snapshot - MarketScreener

Aug 11, 2025
pulisher
Aug 11, 2025

Earnings call transcript: Arcturus Therapeutics Q2 2025 results miss expectations - Investing.com

Aug 11, 2025
pulisher
Aug 11, 2025

Arcturus Therapeutics Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 11, 2025
pulisher
Aug 11, 2025

Arcturus Therapeutics Q2 net loss narrows - MarketScreener

Aug 11, 2025
pulisher
Aug 11, 2025

Arcturus Therapeutics shares edge higher despite earnings miss in Q2 - Investing.com India

Aug 11, 2025
pulisher
Aug 11, 2025

Arcturus Therapeutics shares edge higher despite earnings miss in Q2 By Investing.com - Investing.com Australia

Aug 11, 2025
pulisher
Aug 11, 2025

Arcturus Therapeutics Q2 2025 Financial Update - TradingView

Aug 11, 2025
pulisher
Aug 11, 2025

Short interest data insights for Arcturus Therapeutics Holdings Inc.Historical Market Behavior and Trend Summary - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Risk vs reward if holding onto Arcturus Therapeutics Holdings Inc.Swing Trade Timing with Daily Forecast - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Multi factor analysis applied to Arcturus Therapeutics Holdings Inc.High Yield Signals with Entry Timing - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Arcturus Therapeutics Q2 2025 Earnings Preview: Analysts Expect EPS of -$0.87, Revenue of $18.71M. - AInvest

Aug 10, 2025
pulisher
Aug 08, 2025

Arcturus Therapeutics Holdings Inc expected to post a loss of 89 cents a shareEarnings Preview - TradingView

Aug 08, 2025
pulisher
Aug 08, 2025

What To Expect From Arcturus Therapeutics Holdings Inc (ARCT) Q2 2025 Earnings - GuruFocus

Aug 08, 2025
pulisher
Aug 05, 2025

Lipid Nanoparticles Market Industry Trends, Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2034 - GlobeNewswire Inc.

Aug 05, 2025
pulisher
Aug 05, 2025

Tango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Aug 05, 2025
pulisher
Aug 03, 2025

Is Arcturus Therapeutics Holdings Inc. stock overvalued or undervaluedHigh-yield portfolio picks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in Arcturus Therapeutics Holdings Inc. stockRapid return acceleration - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Arcturus Therapeutics Holdings Inc. compare to its industry peersFree Risk Assessment Services - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are analysts’ price targets for Arcturus Therapeutics Holdings Inc. in the next 12 monthsBuild a winning investment portfolio - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

When is Arcturus Therapeutics Holdings Inc. stock expected to show significant growthDiscover breakthrough stocks before the crowd - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Arcturus Therapeutics Holdings Inc. a growth stock or a value stockGet professional guidance for market timing - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What catalysts could drive Arcturus Therapeutics Holdings Inc. stock higher in 2025Get alerts on high-potential stock breakouts - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What drives Arcturus Therapeutics Holdings Inc. stock priceAchieve rapid financial growth with smart picks - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

What is Arcturus Therapeutics Holdings Inc. company’s growth strategyTremendous financial leverage - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are Arcturus Therapeutics Holdings Inc. company’s key revenue driversRapid return acceleration - Jammu Links News

Aug 02, 2025

Arcturus Therapeutics Holdings Inc (ARCT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
大文字化:     |  ボリューム (24 時間):